Literature DB >> 23836841

Inflammation and schizophrenia: alterations in cytokine levels and perturbation in antioxidative defense systems.

A K Al-Asmari1, Md W Khan.   

Abstract

OBJECTIVE: Although several theories have been proposed including developmental/neurodegenerative processes, neurotransmitter abnormalities, viral infection, and immune dysfunction, the exact causative factor of schizophrenia is unclear. A relationship between inflammation and schizophrenia has been supported by abnormal cytokine production and altered antioxidant status. This study was aimed to examine the alterations in serum oxidative-antioxidative status and cytokine levels of schizophrenic patients.
METHODS: A total of 91 schizophrenic patients from Saudi Arabia and 50 age- and sex-matched healthy controls were enrolled in the present study. Fresh blood samples were collected to measure the levels of cytokines and markers of oxidative stress by spectrophotometric assays simultaneously.
RESULTS: We observed that there was a significant increase in the levels of tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 and a decrease in the levels of interferon-γ. Lipid peroxides are elevated in serum, while total-sulfhydryl levels were decreased. Also, the activities of superoxide dismutase and glutathione peroxidase were decreased, while the activities of catalase, glutathione reductase, and myeloperoxidase were found to be elevated in serum.
CONCLUSION: We conclude that inflammation resulting from dysregulation of cytokines and altered antioxidant systems may play a critical role in the etiology of schizophrenia.

Entities:  

Keywords:  Schizophrenia; antioxidants; inflammation; inflammatory cytokines; oxidative stress

Mesh:

Substances:

Year:  2013        PMID: 23836841     DOI: 10.1177/0960327113493305

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  16 in total

1.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

Review 2.  The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain.

Authors:  S Kanji; T M Fonseka; V S Marshe; V Sriretnakumar; M K Hahn; D J Müller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-17       Impact factor: 5.270

3.  Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.

Authors:  Charllyany Sabino Custódio; Bruna Stefânia Ferreira Mello; Adriano José Maia Chaves Filho; Camila Nayane de Carvalho Lima; Rafaela Carneiro Cordeiro; Fábio Miyajima; Gislaine Z Réus; Silvânia Maria Mendes Vasconcelos; Tatiana Barichello; João Quevedo; Antônio Carlos de Oliveira; David Freitas de Lucena; Danielle S Macedo
Journal:  Mol Neurobiol       Date:  2017-05-23       Impact factor: 5.590

4.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

5.  Elevated plasma F2-isoprostane levels in schizophrenia.

Authors:  Ellen E Lee; Lisa T Eyler; Owen M Wolkowitz; Averria Sirkin Martin; Chase Reuter; Helena Kraemer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-06-16       Impact factor: 4.939

6.  Inflammation and Oxidative Stress in Deficit Schizophrenia.

Authors:  Ferdi KÖŞger; Semra YİĞİtaslan; Altan EŞsİzoĞlu; Gülcan GÜleÇ; Reyhan DaĞ KarataŞ; Sinem Sevİl DeĞİrmencİ
Journal:  Noro Psikiyatr Ars       Date:  2020-09-21       Impact factor: 1.339

Review 7.  Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.

Authors:  Franziska A Radtke; Gareth Chapman; Jeremy Hall; Yasir A Syed
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

8.  Effects of the modified electric convulsive treatment (MECT) on cell factors of schizophrenia.

Authors:  Yong-Fang Guo; Hua-Bin Fu; Zhi-Yuan Liu; Wei Lu; Ke-Yong Luo; Hong-Ri Zhu; Wei-Dong Ning; Feng Chen; Li-Yu Yang; Xiao-Dong Zhou
Journal:  Exp Ther Med       Date:  2017-01-20       Impact factor: 2.447

9.  Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.

Authors:  Maria Fiorentino; Anna Sapone; Stefania Senger; Stephanie S Camhi; Sarah M Kadzielski; Timothy M Buie; Deanna L Kelly; Nicola Cascella; Alessio Fasano
Journal:  Mol Autism       Date:  2016-11-29       Impact factor: 7.509

10.  Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia.

Authors:  Nuno Trovão; Joana Prata; Orlando VonDoellinger; Susana Santos; Mário Barbosa; Rui Coelho
Journal:  Psychiatry Investig       Date:  2019-03-07       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.